Improvements in Recurrence-Free Survival in Early Stages of Colorectal Cancer Will Limit Growth of Drug Treatment Opportunities for Advanced Disease
BURLINGTON, Mass., Dec. 16, 2010 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that projected improvements in recurrence-free survival in early stages of colorectal cancer is the most important factor limiting drug treatment opportunities for advanced disease. According to analysis of Pharmacor Patient Flow Model Colorectal Cancer, the growth in drug treatment opportunities for advanced disease will be limited to 15 percent between 2009 and 2024.
"Drug treatment opportunities for advanced colorectal cancer will be limited because of a sustained decrease in the recurrence risk in early stages of the disease," said Decision Resources Epidemiologist Donal Minihan, M.V.B., Ph.D. "Yet, aging population trends will be responsible for growth in the number of diagnosed incident cases of colorectal cancer in all major markets, resulting in a 27 percent growth in drug treatment opportunities for newly diagnosed cases of colorectal cancer."
The findings are derived from Decision Resources' Pharmacor Patient Flow Models which utilize Decision Resources proprietary suite of epidemiological models. With Pharmacor Patient Flow Models, users can build their own oncology patient flow model and/or validate the assumptions behind their own internal models. This interactive tool allows users to track changing disease and population dynamics over a 15-year annualized forecast, improve their modeling accuracy with clearly depicted methods and transparent assumptions and identify untapped market potential within lines of therapy. Pharmacor Patient Flow Models are available as an add-on product to the Pharmacor advisory service.
About Decision ResourcesDecision Resources (www.decisionresources.com) is a world leader in market research publications, advisory services and consulting designed to help clients shape